Chimerix.

PositionTRIANGLE: DURHAM

Drug developer Chimerix sold the rights to produce an oral antiviral that treats smallpox for $236 million in a contract with Maryland-based Emergent BioSolutions. The agreement could be worth as much as...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT